Nora Franceschini1, Yu Deng2, Michael F Flessner3, John H Eckfeldt4, Holly J Kramer5, James P Lash6, David J Lee7, Michal L Melamed8, Ashley E Moncrieft7, Ana C Ricardo6, Sylvia E Rosas9, Robert C Kaplan8, Leopoldo Raij7, Jianwen Cai2. 1. Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA. 2. Collaborative Studies Coordinating Center, Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. 3. National Institute of Diabetes, Digestive, and Kidney Disease, Bethesda, MD, USA. 4. Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA. 5. Division of Nephrology, Loyola University, Maywood, IL, USA. 6. Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA. 7. University of Miami, Miami, FL, USA. 8. Albert Einstein College of Medicine, New York, NY, USA. 9. Joslin Diabetes Center, Harvard University, Boston, MA, USA.
Abstract
BACKGROUND: Intermittent smoking is prevalent among Hispanics, but little is known about whether this smoking pattern associates with increased chronic kidney disease (CKD) risk in this population. The objective of the present study is to identify patterns of exposure associated with CKD in US Hispanics. METHODS: We used cross-sectional data on 15 410 participants of the Hispanics Community Health Study/the Study of Latinos, a population-based study of individuals aged 18-74 years, recruited in 2008 to 2011 from four US field centers (Bronx, NY; Chicago, IL; Miami, FL; San Diego, CA). Smoking exposure was obtained through a questionnaire. CKD was defined by an estimated glomerular filtration rate of <60 mL/min/1.73 m(2) or a urine albumin-to-creatinine ratio of ≥30 mg/g. RESULTS: Approximately 14% of individuals were daily and 7% were intermittent smokers, and 16% were past smokers. There was a significant interaction between smoking status and pack-years of exposure (P = 0.0003). In adjusted models, there was an increased odds of CKD among daily, intermittent and past smokers by pack-years compared with never smokers. The association of intermittent smokers was significant at 10 pack-years [odds ratio (OR) = 1.38, 95% confidence intervals (CI) 1.06, 1.81], whereas for daily smokers this association was observed at 40 pack-years (OR = 1.43, 95% CI 1.09, 1.89). CONCLUSIONS: Our findings of increased risk of CKD among Hispanics who are intermittent smokers support screening and smoking cessation interventions targeted to this population for the prevention of CKD. It also suggests novel mechanistic pathways for kidney toxicity that should be further explored in future studies.
BACKGROUND: Intermittent smoking is prevalent among Hispanics, but little is known about whether this smoking pattern associates with increased chronic kidney disease (CKD) risk in this population. The objective of the present study is to identify patterns of exposure associated with CKD in US Hispanics. METHODS: We used cross-sectional data on 15 410 participants of the Hispanics Community Health Study/the Study of Latinos, a population-based study of individuals aged 18-74 years, recruited in 2008 to 2011 from four US field centers (Bronx, NY; Chicago, IL; Miami, FL; San Diego, CA). Smoking exposure was obtained through a questionnaire. CKD was defined by an estimated glomerular filtration rate of <60 mL/min/1.73 m(2) or a urine albumin-to-creatinine ratio of ≥30 mg/g. RESULTS: Approximately 14% of individuals were daily and 7% were intermittent smokers, and 16% were past smokers. There was a significant interaction between smoking status and pack-years of exposure (P = 0.0003). In adjusted models, there was an increased odds of CKD among daily, intermittent and past smokers by pack-years compared with never smokers. The association of intermittent smokers was significant at 10 pack-years [odds ratio (OR) = 1.38, 95% confidence intervals (CI) 1.06, 1.81], whereas for daily smokers this association was observed at 40 pack-years (OR = 1.43, 95% CI 1.09, 1.89). CONCLUSIONS: Our findings of increased risk of CKD among Hispanics who are intermittent smokers support screening and smoking cessation interventions targeted to this population for the prevention of CKD. It also suggests novel mechanistic pathways for kidney toxicity that should be further explored in future studies.
Authors: Aruni Bhatnagar; Laurie P Whitsel; Kurt M Ribisl; Chris Bullen; Frank Chaloupka; Mariann R Piano; Rose Marie Robertson; Timothy McAuley; David Goff; Neal Benowitz Journal: Circulation Date: 2014-08-24 Impact factor: 29.690
Authors: Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey Journal: N Engl J Med Date: 2012-07-05 Impact factor: 91.245
Authors: Paul D Sorlie; Larissa M Avilés-Santa; Sylvia Wassertheil-Smoller; Robert C Kaplan; Martha L Daviglus; Aida L Giachello; Neil Schneiderman; Leopoldo Raij; Gregory Talavera; Matthew Allison; Lisa Lavange; Lloyd E Chambless; Gerardo Heiss Journal: Ann Epidemiol Date: 2010-08 Impact factor: 3.797
Authors: Nancy L Saccone; Leslie S Emery; Tamar Sofer; Stephanie M Gogarten; Diane M Becker; Erwin P Bottinger; Li-Shiun Chen; Robert C Culverhouse; Weimin Duan; Dana B Hancock; H Dean Hosgood; Eric O Johnson; Ruth J F Loos; Tin Louie; George Papanicolaou; Krista M Perreira; Erik J Rodriquez; Claudia Schurmann; Adrienne M Stilp; Adam A Szpiro; Gregory A Talavera; Kent D Taylor; James F Thrasher; Lisa R Yanek; Cathy C Laurie; Eliseo J Pérez-Stable; Laura J Bierut; Robert C Kaplan Journal: Nicotine Tob Res Date: 2018-03-06 Impact factor: 4.244
Authors: Madelyn Klugman; H Dean Hosgood; Simin Hua; Xiaonan Xue; Thanh-Huyen T Vu; Krista M Perreira; Sheila F Castañeda; Jianwen Cai; James R Pike; Martha Daviglus; Robert C Kaplan; Carmen R Isasi Journal: Ann Epidemiol Date: 2020-06-23 Impact factor: 3.797